SCHEMBL9607099

SCHEMBL9607099

CCCCC/C=C\CCCCCCCC(O)CC/C=C\C(O)CC(O)C/C=C\CCC(C)=O

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.56
FFAR4 Q5NUL3 2/20 0.56
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
FAAH O00519 2/20 0.50
LTB4R Q15722 2/20 0.42
ALDH1A1 P00352 1/20 0.42
LTB4R2 Q9NPC1 1/20 0.42
PPARG P37231 2/20 0.41
GPR132 Q9UNW8 1/20 0.41
MEN1 O00255 1/20 0.39
CYP3A4 P08684 1/20 0.39
KMT2A Q03164 1/20 0.39
GPR84 Q9NQS5 1/20 0.39
CETP P11597 1/20 0.39
OXER1 Q8TDS5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9607135 0.91 FFAR1 (0.67) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL9607096 0.89 FFAR1 (0.70) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL9607097 0.88 NFKB1 (0.53) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL9607098 0.86 NFKB1 (0.62) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL20039910 0.81 FFAR1 (0.78) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL26868694 0.81 FFAR1 (0.78) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL13352197 0.81 FFAR1 (0.78) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL26393254 0.81 FFAR1 (0.78) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL19651148 0.80 FFAR1 (0.57) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL9607132 0.78 FFAR1 (0.84) FFAR1FFAR4NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10006925-B2 Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps Universal Diagnostics, S. L. (ES) 2018-06-26 US disclosed
US-20170343567-A1 METHODS AND SYSTEMS FOR METABOLITE AND/OR LIPID-BASED DETECTION OF COLORECTAL CANCER AND/OR ADENOMATOUS POLYPS Universal Diagnostics, S.A. (ES) 2017-11-30 US disclosed
US-20120136057-A1 HYDROXY FATTY ACID COMPOUNDS AND USES THEREOF FOR DISEASE TREATMENT AND DIAGNOSIS PHENOMENOME DISCOVERIES INC. (CA) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136057-A1 HYDROXY FATTY ACID COMPOUNDS AND USES THEREOF FOR DISEASE TREATMENT AND DIAGNOSIS HCAR2, ALOX5, ALOX12 FFAR1 41/4885FFAR4 12/4885NFKB1 514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.